GLMD icon

Galmed Pharmaceuticals
GLMD

Overview Fund Activity

26 hedge funds and large institutions have $11.8M invested in Galmed Pharmaceuticals in 2021 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 6 increasing their positions, 5 reducing their positions, and 3 closing their positions.

Holders
26
Holders Change
+1
Holders Change %
+4%
% of All Funds
0.46%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
4
Increased
6
Reduced
5
Closed
3
Calls
$80K
Puts
$504K
Net Calls
-$424K
Net Calls Change
-$311K

Top Buyers

1
TI
1
Tidal Investments
Wisconsin
$69K
2
RJA
2
Raymond James & Associates
Florida
$641K
3
Susquehanna International Group
3
Susquehanna International Group
Pennsylvania
$124K
4
Millennium Management
4
Millennium Management
New York
$36K
5
Geode Capital Management
5
Geode Capital Management
Massachusetts
$75K

Top Sellers

1
NCM
1
Nantahala Capital Management
Connecticut
$1.05M
2
II
2
Ibex Investors
Colorado
$3.33M
3
Morgan Stanley
3
Morgan Stanley
New York
$459K
4
JF
4
Jump Financial
Illinois
$0
5
Two Sigma Advisers
5
Two Sigma Advisers
New York
$0
Name Market Value Shares Shares
Change 		Shares
Change %
JF
26
Jump Financial
Illinois
– – -16,800 Closed
Two Sigma Advisers
27
Two Sigma Advisers
New York
– – -15,200 Closed
SFI
28
Susquehanna Fundamental Investments
Pennsylvania
– – -10,200 Closed
CG
29
Cutler Group
California
– – – –
CFGS
30
Concourse Financial Group Securities
Alabama
– – – –
UBS Group
31
UBS Group
Switzerland
$0 160 +160 New
1
2